FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Glenn Heller

Research Profile

Procedures

Disorders

Concepts & Ideas

Living Beings

Anatomy

T-Lymphocytes

Chemicals & Drugs

Prostate Specific Antigen

Co-author Network

Publications

TOP 3
Joshua N Honeyman; Molly A Knowles; Rachel Kobos; Maureen P McEvoy; Edward Riachy; Barrie S Rich; Neerav Shukla; Peter G Steinherz; Suzanne L Wolden; Glenn Heller; Michael P LaQuaglia
Factors associated with relapse and survival in Wilms tumor: a multivariate analysis.
Glenn Heller
A measure of explained risk in the proportional hazards model.
Gopa Iyer; Steven M Larson; Michael J Morris; Dana Elizabeth Rathkopf; Neal Rosen; Howard I Scher; Lawrence H Schwartz; Susan F Slovin; Tracy Curley; Anthony Delacruz; Merrill J Egorin; Glenn Heller; S Percy Ivy; Macaulay Steers; Qing Ye; David B Solit
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Glenn Heller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Joshua N Honeyman; Molly A Knowles; Rachel Kobos; Maureen P McEvoy; Edward Riachy; Barrie S Rich; Neerav Shukla; Peter G Steinherz; Suzanne L Wolden; Glenn Heller; Michael P LaQuaglia
Factors associated with relapse and survival in Wilms tumor: a multivariate analysis.
Journal of pediatric surgery 2012;47(6):1228-33.
2012: Glenn Heller
A measure of explained risk in the proportional hazards model.
Biostatistics (Oxford, England) 2012;13(2):315-25.
2012: Gopa Iyer; Steven M Larson; Michael J Morris; Dana Elizabeth Rathkopf; Neal Rosen; Howard I Scher; Lawrence H Schwartz; Susan F Slovin; Tracy Curley; Anthony Delacruz; Merrill J Egorin; Glenn Heller; S Percy Ivy; Macaulay Steers; Qing Ye; David B Solit
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors.
Cancer chemotherapy and pharmacology 2012;69(4):1089-97.
2012: Ekaterina Doubrovina; Diane George; Cyrus Hedvat; Glenn Heller; Ann Jakubowski; Nancy A Kernan; Ramzi Khalaf; Guenther Koehne; Banu Oflaz-Sozmen; Sara Abramson; Juliet N Barker; Farid Boulad; Hugo Castro-Malaspina; Joanne F Chou; Esperanza B Papadopoulos; Susan E Prockop; Andromachi Scaradavou; Trudy N Small; Julie Teruya-Feldstein; James W Young; Richard J O'Reilly
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation.
Blood 2012;119(11):2644-56.
2012: Elizabeth R Dennis; Josef J Fox; Glenn Heller; Xiaoyu Jia; Steven M Larson; Irina S Mezheritskiy; Howard I Scher; Heiko Schoder; Ryan D Stephenson; Michael J Morris
Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(5):519-24.
2011: Daniel C Danila; Martin Fleisher; Glenn Heller; Margaret A Leversha; Hans Lilja; Arturo Molina; Charles L Sawyers; Aseem Anand; Long Cao; Clifford Sung; Howard I Scher
TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate.
European urology 2011;60(5):897-904.
2011: Joanne F Chou; Catherine Copeland; Glenn Heller; Nancy A Kernan; Molly A Knowles; Rachel Kobos; Esperanza B Papadopoulos; Susan E Prockop; Julianne Ruggiero; Andromachi Scaradavou; Joanne Torok-Castanza; Nicole Zakak; Anne Casson; Trudy N Small
Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(11):1708-13.
2011: Howard I Scher; Michael J Morris; Ethan Basch; Glenn Heller
End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(27):3695-704.
2011: Doris M Ponce; Susan Prockop; Andromachi Scaradavou; Trudy Small; Marcel R van den Brink; James W Young; Junting Zheng; Farid Boulad; Hugo Castro-Malaspina; Sergio Giralt; Anne Marie Gonzales; Glenn Heller; Katharine Hsu; Ann A Jakubowski; Robert R Jenq; Nancy A Kernan; Rachel Kobos; Guenther Koehne; Marissa Lubin; Richard J O'Reilly; Esperanza B Papadopoulos; Miguel-Angel Perales; Juliet N Barker
Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(9):1316-26.
2011: Glenn Heller
Proportional hazards regression with interval censored data using an inverse probability weight.
Lifetime data analysis 2011;17(3):373-85.
2011: Howard I Scher; Xiaoyu Jia; Kim Chi; Ronald de Wit; William R Berry; Peter Albers; Brian Henick; David Waterhouse; Dean J Ruether; Peter J Rosen; Anthony A Meluch; Luke T Nordquist; Peter M Venner; Axel Heidenreich; Luis Chu; Glenn Heller
Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(16):2191-8.
2010: Lamis K Eldjerou; Sonali Chaudhury; Ada Baisre-de Leon; Mai He; Maria E Arcila; Glenn Heller; Richard J O'Reilly; Juliet N Barker; Malcolm A S Moore
An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.
Blood 2010;116(19):3999-4006.
2010: Juliet N Barker; Courtney E Byam; Nancy A Kernan; Sinda S Lee; Rebecca M Hawke; Kathleen A Doshi; Deborah S Wells; Glenn Heller; Esperanza B Papadopoulos; Andromachi Scaradavou; James W Young; Marcel R M van den Brink
Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(11):1541-8.
2010: Miguel-Angel Perales; Robert R Jenq; Jenna Goldberg; A S Wilton; S S E Lee; Hugo Castro-Malaspina; Katharine C Hsu; Esperanza B Papadopoulos; Marcel R M van den Brink; Farid Boulad; Nancy A Kernan; Trudy N Small; S Wolden; N H Collins; M Chiu; Glenn Heller; Richard J O'Reilly; T Kewalramani; James W Young; Ann Jakubowski
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.
Bone marrow transplantation 2010;45(9):1408-16.
2010: Sonal Bhandari; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Steven M Larson; Samuel Yeh; Glenn Heller; Charles A Sklar
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma.
Pediatric blood & cancer 2010;55(1):76-80.
2010: Mithat Gonen; Glenn Heller
Lehmann family of ROC curves.
Medical decision making : an international journal of the Society for Medical Decision Making 2010;30(4):509-17.
2010: Olaf Penack; Erik Henke; David Suh; Chris G King; Odette M Smith; Il-Kang Na; Amanda M Holland; Arnab Ghosh; Sydney X Lu; Robert R Jenq; Chen Liu; George F Murphy; Theresa T Lu; Chad May; David A Scheinberg; Ding Cheng Gao; Vivek Mittal; Glenn Heller; Robert Benezra; Marcel R M van den Brink
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.
Journal of the National Cancer Institute 2010;102(12):894-908.
2010: Kevin J Patel; Robert D. Rice; Rebecca Hawke; Miguel R Abboud; Glenn Heller; Andromachi Scaradavou; James W Young; Juliet N Barker
Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(3):435-40.
2010: Richard Kolesnick; Marcel R M van den Brink; Glenn Heller; Jimmy A Rotolo
Response: Sample size and statistical comparisons of GVHD rates in pediatric Niemann-Pick disease patients.
Blood 2010;115(2):436.
2010: Cami S Sima; Katherine S Panageas; Glenn Heller; Deborah Schrag
Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data.
Applied health economics and health policy 2010;8(1):37-51.
2009: Ethan Basch; Xiaoyu Jia; Glenn Heller; Allison Barz; Laura Sit; Michael Fruscione; Mark Appawu; Alexia Iasonos; Thomas Atkinson; Shari Goldfarb; Ann Culkin; Mark G Kris; Deborah Schrag
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.
Journal of the National Cancer Institute 2009;101(23):1624-32.
2009: Juliet N Barker; Miguel R Abboud; Robert D. Rice; Rebecca Hawke; Allison Schaible; Glenn Heller; Vincent La Russa; Andromachi Scaradavou
A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1596-602.
2009: Nina Cohen; Coralia N Mihu; Susan K Seo; Dick Chung; Joanne Chou; Glenn Heller; Genovefa A Papanicolaou
Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1337-41.
2009: Michael J Morris; Neeta Pandit-Taskar; Jorge Carrasquillo; Chaitanya R Divgi; Susan F Slovin; W Kevin Kelly; Dana Elizabeth Rathkopf; Gretchen A Gignac; David B Solit; Lawrence H Schwartz; Ryan D Stephenson; Christina Hong; Anthony Delacruz; Tracy Curley; Glenn Heller; Xiaoyu Jia; Joseph A O'Donoghue; Steven M Larson; Howard I Scher
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(15):2436-42.
2009: Margaret A Leversha; Jialian Han; Zahra Asgari; Daniel C Danila; Oscar Lin; Rita Gonzalez-Espinoza; Aseem Anand; Hans Lilja; Glenn Heller; Martin Fleisher; Howard I Scher
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2091-7.
2009: Howard I Scher; Xiaoyu Jia; Johann S de Bono; Martin Fleisher; Kenneth J Pienta; Derek Raghavan; Glenn Heller
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.
The lancet oncology 2009;10(3):233-9.
2009: Lucy W Kappel; Gabrielle Goldberg; Christopher G King; David Y Suh; Odette M Smith; Cassandra Ligh; Amanda M Holland; Jeremy Grubin; Nicholas M Mark; Chen Liu; Yoichiro Iwakura; Glenn Heller; Marcel R M van den Brink
IL-17 contributes to CD4-mediated graft-versus-host disease.
Blood 2009;113(4):945-52.
2008: Gretchen A Gignac; Michael J Morris; Glenn Heller; Lawrence H Schwartz; Howard I Scher
Assessing outcomes in prostate cancer clinical trials: a twenty-first century tower of Babel.
Cancer 2008;113(5):966-74.
2008: Dana Elizabeth Rathkopf; Michael A Carducci; Michael J Morris; Susan F Slovin; Mario A Eisenberger; Roberto Pili; Samuel R Denmeade; Moshe Kelsen; Tracy Curley; Melinda Halter; Connie Collins; Martin Fleisher; Glenn Heller; Sharyn D Baker; Howard I Scher
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):2959-65.
2008: Johannes L Zakrzewski; David Suh; John C Markley; Odette M Smith; Christopher King; Gabrielle Goldberg; Robert R Jenq; Amanda M Holland; Jeremy Grubin; Javier Cabrera Perez; Renier J Brentjens; Sydney X Lu; Gabrielle Rizzuto; Derek B Sant'Angelo; Isabelle Riviere; Michel Sadelain; Glenn Heller; Juan Carlos Zúñiga-Pflücker; Chen Lu; Marcel R M van den Brink
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.
Nature biotechnology 2008;26(4):453-61.
2008: Hugo Castro-Malaspina; Ann A Jabubowski; Esperanza B Papadopoulos; Farid Boulad; James W Young; Nancy A Kernan; Miguel-Angel Perales; Trudy N Small; Katharine C Hsu; Michelle Chiu; Glenn Heller; Nancy H Collins; Suresh C Jhanwar; Marcel R M van den Brink; Stephen D Nimer; Richard J O'Reilly
Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(4):458-68.
2008: Vincent A Miller; Gregory J Riely; Maureen F Zakowski; Allan R Li; Jyoti D Patel; Robert T Heelan; Mark G Kris; Alan B Sandler; David P Carbone; Anne Tsao; Roy S Herbst; Glenn Heller; Marc Ladanyi; William Pao; David H Johnson
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1472-8.
2008: Sonali Chaudhury; Arleen D Auerbach; Nancy A Kernan; Trudy N Small; Susan E Prockop; Andromachi Scaradavou; Glenn Heller; Suzanne L Wolden; Richard J O'Reilly; Farid Boulad
Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
British journal of haematology 2008;140(6):644-55.
2008: Theo D Kim; Theis H Terwey; Johannes L Zakrzewski; David Suh; Adam A Kochman; Megan E Chen; Chris G King; Chiara Borsotti; Jeremy Grubin; Odette M Smith; Glenn Heller; Chen Liu; George F Murphy; Onder Alpdogan; Marcel R M van den Brink
Organ-derived dendritic cells have differential effects on alloreactive T cells.
Blood 2008;111(5):2929-40.
2007: Daniel C Danila; Glenn Heller; Gretchen A Gignac; Rita Gonzalez-Espinoza; Aseem Anand; Erika Tanaka; Hans Lilja; Lawrence H Schwartz; Steven M Larson; Martin Fleisher; Howard I Scher
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):7053-8.
2007: Matthias T Stephan; Vladimir Ponomarev; Renier J Brentjens; Alex H Chang; Konstantin V Dobrenkov; Glenn Heller; Michel Sadelain
T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection.
Nature medicine 2007;13(12):1440-9.
2007: Michael J Morris; W Kevin Kelly; Susan F Slovin; Charles Ryan; Caitlin Eicher; Glenn Heller; Howard I Scher
A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer.
The Journal of urology 2007;178(6):2378-83; discussion 2383-4.
2007: Joseph H Chewning; Hugo Castro-Malaspina; Ann Jakubowski; Nancy A Kernan; Esperanza B Papadopoulos; Trudy N Small; Glenn Heller; Katharine C Hsu; Miguel-Angel Perales; Marcel R M van den Brink; James W Young; Susan E Prockop; Nancy H Collins; Richard J O'Reilly; Farid Boulad
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(11):1313-23.
2007: Junli Yu; Glenn Heller; Joseph H Chewning; Sungjin Kim; Wayne M Yokoyama; Katharine C Hsu
Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(9):5977-89.
2007: Jianda Yuan; Ryan Kendle; Joanna Ireland; Glenn Heller; Michel Sadelain; James W Young; Isabelle Riviere
Scalable expansion of potent genetically modified human langerhans cells in a closed system for clinical applications.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(6):634-43.
2007: Miguel-Angel Perales; Nicole Ishill; W A Lomazow; David M Weinstock; Esperanza B Papadopoulos; H Dastigir; Michelle Chiu; Farid Boulad; Hugo Castro-Malaspina; Glenn Heller; Ann Jakubowski; Richard J O'Reilly; Trudy N Small; James W Young; Nancy A Kernan
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
Bone marrow transplantation 2007;40(5):481-6.
2007: Teresa Ramirez-Montagut; Andrew Chow; Adam A Kochman; Odette M Smith; David Suh; Hamad Sindhi; Sydney Lu; Chiara Borsotti; Jeremy Grubin; Neel Patel; Theis H Terwey; Theo D Kim; Glenn Heller; George F Murphy; Chen Liu; Onder Alpdogan; Marcel R M van den Brink
IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):1669-80.
2007: Glenn Heller; Michael W Kattan; Howard I Scher
Improving the decision to pursue a phase 3 clinical trial by adjusting for patient-specific factors in evaluating phase 2 treatment efficacy data.
Medical decision making : an international journal of the Society for Medical Decision Making 2007;27(4):380-6.
2007: Wassim Chemaitilly; Farid Boulad; Glenn Heller; Nancy A Kernan; Trudy N Small; Richard J O'Reilly; Charles A Sklar
Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation.
Bone marrow transplantation 2007;40(1):29-35.
2007: David R Shaffer; Margaret Leversha; Daniel C Danila; Oscar Lin; Rita Gonzalez-Espinoza; Bin Gu; Aseem Anand; Katherine Smith; Peter Maslak; Gerald V Doyle; Leon W M M Terstappen; Hans Lilja; Glenn Heller; Martin Fleisher; Howard I Scher
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2023-9.
2007: Rochelle Bagatell; Lia Gore; Merrill J Egorin; Richard Ho; Glenn Heller; Nichole Boucher; Eleanor G Zuhowski; James A Whitlock; Stephen P Hunger; Aru Narendran; Howard M Katzenstein; Robert J Arceci; Jessica Boklan; Cynthia E Herzog; Luke Whitesell; S Percy Ivy; Tanya M Trippett
Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1783-8.
2007: David B Solit; S Percy Ivy; Catherine Kopil; Rachel Sikorski; Michael J Morris; Susan F Slovin; W Kevin Kelly; Anthony Delacruz; Tracy Curley; Glenn Heller; Steven M Larson; Lawrence H Schwartz; Merrill J Egorin; Neal Rosen; Howard I Scher
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1775-82.
2007: Howard I Scher; Mary Warren; Glenn Heller
The association between measures of progression and survival in castrate-metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(5):1488-92.
2007: Trudy N Small; James W Young; Hugo Castro-Malaspina; Susan E Prockop; Andrew Wilton; Glenn Heller; Farid Boulad; Michelle Chiu; Katharine C Hsu; Ann Jakubowski; Nancy A Kernan; Miguel-Angel Perales; Richard J O'Reilly; Esperanza B Papadopoulos
Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(2):235-44.
2007: Glenn Heller; Jing Qin
Inference on the limiting false discovery rate and the p-value threshold parameter assuming weak dependence between gene expression levels within subject.
Statistical applications in genetics and molecular biology 2007;6():Article14.
2006: David Feltquate; Luke Nordquist; Caitlin Eicher; Michael J Morris; Oren Smaletz; Susan F Slovin; Tracy Curley; Andrew Wilton; Martin Fleisher; Glenn Heller; Howard I Scher
Rapid androgen cycling as treatment for patients with prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7414-21.
2006: Mark T Fleming; Michael J Morris; Glenn Heller; Howard I Scher
Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials.
Nature clinical practice. Oncology 2006;3(12):658-67.
2006: Miguel-Angel Perales; Adi Diab; Adam D Cohen; Deonka W Huggins; Jose A. Guevara-Patino; Vanessa M Hubbard; Manuel E Engelhorn; Adam A Kochman; Jeffrey M Eng; Fariborz Mortazavi; Onder Alpdogan; Theis H Terwey; Glenn Heller; Jedd D Wolchok; Alan N Houghton; Marcel R M van den Brink
DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(6):4159-67.
2006: Johannes L Zakrzewski; Adam A Kochman; Sydney X Lu; Theis H Terwey; Theo D Kim; Vanessa M Hubbard; Stephanie J Muriglan; David Suh; Odette M Smith; Jeremy Grubin; Neel Patel; Andrew Chow; Javier Cabrera Perez; Radhika Radhakrishnan; Adi Diab; Miguel-Angel Perales; Gabrielle Rizzuto; Ewa Menet; Eric G Pamer; Glenn Heller; Juan Carlos Zúñiga-Pflücker; Onder Alpdogan; Marcel R M van den Brink
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.
Nature medicine 2006;12(9):1039-47.
2006: Berrin Ergun-Longmire; Ann C Mertens; Pauline A Mitby; Jing Qin; Glenn Heller; Weiji Shi; Yutaka Yasui; Leslie L Robison; Charles A Sklar
Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor.
The Journal of clinical endocrinology and metabolism 2006;91(9):3494-8.
2006: Glenn Heller
Power calculations for preclinical studies using a K-sample rank test and the Lehmann alternative hypothesis.
Statistics in medicine 2006;25(15):2543-53.
2006: Ellin Berman; Maria Nicolaides; ROBERT G MAKI; Martin Fleisher; Suzanne Chanel; Kelly Scheu; Bri-Anne Wilson; Glenn Heller; Nicholas P Sauter
Altered bone and mineral metabolism in patients receiving imatinib mesylate.
The New England journal of medicine 2006;354(19):2006-13.
2006: Barry J Kappel; Javier Pinilla-Ibarz; Adam A Kochman; Jeffrey M Eng; Vanessa M Hubbard; Ingrid Leiner; Eric G Pamer; Glenn Heller; Marcel R M van den Brink; David A Scheinberg
Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.
Blood 2006;107(5):2045-51.
2006: Jianda Yuan; Jean-Baptiste Latouche; Joanna Hodges; Alan N Houghton; Glenn Heller; Michel Sadelain; Isabelle Riviere; James W Young
Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(4):2357-65.
2006: Elisha Waldman; Sydney X Lu; Vanessa M Hubbard; Adam A Kochman; Jeffrey M Eng; Theis H Terwey; Stephanie J Muriglan; Theo D Kim; Glenn Heller; George F Murphy; Chen Liu; Onder Alpdogan; Marcel R M van den Brink
Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine.
Blood 2006;107(4):1703-11.
2005: Susan F Slovin; Andrew Wilton; Glenn Heller; Howard I Scher
Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8669-73.
2005: Theis H Terwey; Theo D Kim; Adam A Kochman; Vanessa M Hubbard; Sydney Lu; Johannes L Zakrzewski; Teresa Ramirez-Montagut; Jeffrey M Eng; Stephanie J Muriglan; Glenn Heller; George F Murphy; Chen Liu; Tulin Budak-Alpdogan; Onder Alpdogan; Marcel R M van den Brink
CCR2 is required for CD8-induced graft-versus-host disease.
Blood 2005;106(9):3322-30.
2005: Vanessa M Hubbard; Jeffrey M Eng; Teresa Ramirez-Montagut; Kartono H Tjoe; Stephanie J Muriglan; Adam A Kochman; Theis H Terwey; Lucy M Willis; Rafaella Schiro; Glenn Heller; George F Murphy; Chen Liu; Onder Alpdogan; Marcel R M van den Brink
Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation.
Blood 2005;106(9):3285-92.
2005: Adam M Boruchov; Glenn Heller; Maria-Concetta Veri; Ezio Bonvini; Jeffrey V Ravetch; James W Young
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions.
The Journal of clinical investigation 2005;115(10):2914-23.
2005: Kathleen W Beekman; Mark T Fleming; Howard I Scher; Susan F Slovin; Nicole Ishill; Glenn Heller; W Kevin Kelly
Second-line chemotherapy for prostate cancer: patient characteristics and survival.
Clinical prostate cancer 2005;4(2):86-90.
2005: Howard I Scher; Michael J Morris; W Kevin Kelly; Lawrence H Schwartz; Glenn Heller
Prostate cancer clinical trial end points: "RECIST"ing a step backwards.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5223-32.
2005: Katharine C Hsu; Carolyn Keever-Taylor; Andrew Wilton; Clara Pinto; Glenn Heller; Knarik Arkun; Richard J O'Reilly; Mary M Horowitz; Bo Dupont
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
Blood 2005;105(12):4878-84.
2005: Kathleen Beekman; Michael J Morris; Susan F Slovin; Glenn Heller; Andrew Wilton; Fernando Bianco; Peter T Scardino; Howard I Scher
Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen.
Urology 2005;65(5):947-52.
2005: Michael J Morris; Timothy Akhurst; Steven M Larson; Marisa Ditullio; Elaina Chu; Karen Siedlecki; David Verbel; Glenn Heller; W Kevin Kelly; Susan F Slovin; Lawrence H Schwartz; Howard I Scher
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3210-6.
2005: Jianda Yuan; Jean-Baptiste Latouche; John L Reagan; Glenn Heller; Isabelle Riviere; Michel Sadelain; James W Young
Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(2):758-66.
2004: Ekaterina Doubrovina; Mikhail Doubrovin; Sangyull Lee; Jae-Hung Shieh; Glenn Heller; Eric G Pamer; Richard J O'Reilly
In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7207-19.
2004: Carrie M Brownstein; Ann C Mertens; Pauline A Mitby; Marilyn Stovall; Jing Qin; Glenn Heller; Leslie L Robison; Charles A Sklar
Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study.
The Journal of clinical endocrinology and metabolism 2004;89(9):4422-7.
2004: Gudrun Ratzinger; Jan Baggers; Maria A de Cos; Jianda Yuan; Tao Dao; John L Reagan; Christian Münz; Glenn Heller; James W Young
Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(4):2780-91.
2004: Charles J Ryan; Michael J Zelefsky; Glenn Heller; Kevin Regan; Steven A Leibel; Howard I Scher; W Kevin Kelly
Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.
Urology 2004;64(1):90-4.
2004: Glenn Heller
Incorporating follow-up time in M-estimation for survival data.
Lifetime data analysis 2004;10(1):51-64.
2004: Michael P LaQuaglia; Brian H Kushner; Wendy Su; Glenn Heller; Kim Kramer; Sara Abramson; Nancy Rosen; Suzanne L Wolden; Nai-Kong V Cheung
The impact of gross total resection on local control and survival in high-risk neuroblastoma.
Journal of pediatric surgery 2004;39(3):412-7; discussion 412-7.
2004: Aleksandra Petrovic; Onder Alpdogan; Lucy M Willis; Jeffrey M Eng; Andrew S Greenberg; Barry J Kappel; Chen Liu; George J Murphy; Glenn Heller; Marcel R M van den Brink
LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.
Blood 2004;103(4):1542-7.
2004: Howard I Scher; Mario A Eisenberger; Anthony V D'Amico; Susan Halabi; Eric J Small; Michael J Morris; Michael W Kattan; Mack Roach; Philip W Kantoff; Kenneth J Pienta; Michael A Carducci; David B Agus; Susan F Slovin; Glenn Heller; W Kevin Kelly; Paul H Lange; Daniel P Petrylak; William Berg; Celestia S Higano; George Wilding; Judd W Moul; Alan W Partin; Christopher Logothetis; Howard R Soule
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):537-56.
2003: Richard M Enmon; Wei-Hong Yang; Ase M Ballangrud; David B Solit; Glenn Heller; Neal Rosen; Howard I Scher; George Sgouros
Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids.
Cancer research 2003;63(23):8393-9.
2003: Michael W Kattan; Glenn Heller; Murray F Brennan
A competing-risks nomogram for sarcoma-specific death following local recurrence.
Statistics in medicine 2003;22(22):3515-25.
2003: Guenther Koehne; Mikhail Doubrovin; Ekaterina Doubrovina; Pat Zanzonico; Humilidad F Gallardo; Anna Ivanova; Julius Balatoni; Julie T Feldstein; Glenn Heller; Chad May; Vladimir Ponomarev; Shutian Ruan; Ronald Finn; Ronald Blasberg; William G Bornmann; Isabelle Riviere; Michel Sadelain; Richard J O'Reilly; Steven M Larson; Juri Gelovani Tjuvajev
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.
Nature biotechnology 2003;21(4):405-13.
2003: Gudrun Ratzinger; John L Reagan; Glenn Heller; Klaus J Busam; James W Young
Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation.
Blood 2003;101(4):1422-9.
2003: David Verbel; W Kevin Kelly; Oren Smaletz; Kevin Regan; Tracy Curley; Glenn Heller; Howard I Scher
Estimating survival benefit in castrate metastatic prostate cancer: decision making in proceeding to a definitive phase III trial.
Urology 2003;61(1):142-4.
2002: Sharon R Lewin; Glenn Heller; Linqi Zhang; Elaine Rodrigues; Eva Skulsky; Marcel R M van den Brink; Trudy N Small; Nancy A Kernan; Richard J O'Reilly; David D Ho; James W Young
Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations.
Blood 2002;100(6):2235-42.
2002: Ellin Berman; Claudia Little; Bonnie Teschendorf; Meaghan Jones; Glenn Heller
Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapy.
Cancer 2002;95(5):1064-70.
2002: David Verbel; Glenn Heller; W Kevin Kelly; Howard I Scher
Quantifying the amount of variation in survival explained by prostate-specific antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(8):2576-9.
2002: Charles A Sklar; Ann C Mertens; Pauline A Mitby; Glenn Occhiogrosso; Jing Qin; Glenn Heller; Yutaka Yasui; Leslie L Robison
Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study.
The Journal of clinical endocrinology and metabolism 2002;87(7):3136-41.
2002: David B Solit; Fuzhong F Zheng; Marija Drobnjak; Pamela N Münster; Brian Higgins; David Verbel; Glenn Heller; William Tong; Carlos Cordon-Cardo; David B Agus; Howard I Scher; Neal Rosen
17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):986-93.
2002: Guenther Koehne; Katherine M Smith; Teresa L Ferguson; Roxanne Y Williams; Glenn Heller; Eric G Pamer; Bo Dupont; Richard J O'Reilly
Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.
Blood 2002;99(5):1730-40.
2002: Howard I Scher; Glenn Heller
Picking the winners in a sea of plenty.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):400-4.
2001: Glenn Heller
An adjustment for a post-randomization variable in the comparison of two treatments for survival.
Statistics in medicine 2001;20(22):3475-85.
2001: Glenn Heller
The Cox proportional hazards model with a partly linear relative risk function.
Lifetime data analysis 2001;7(3):255-77.
2001: Glenn Heller; Jing Qin
Pairwise rank-based likelihood for estimation and inference on the mixture proportion.
Biometrics 2001;57(3):813-7.
2001: Brian H Kushner; Suzanne L Wolden; Michael P LaQuaglia; Kim Kramer; David Verbel; Glenn Heller; Nai-Kong V Cheung
Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2821-8.
2001: Dennis C Coffey; Martha C Kutko; Richard Glick; Lisa M Butler; Glenn Heller; Richard A Rifkind; Paul A Marks; Victoria M Richon; Michael P LaQuaglia
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.
Cancer research 2001;61(9):3591-4.
2001: Kim Kramer; Brian H Kushner; Glenn Heller; Nai-Kong V Cheung
Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.
Cancer 2001;91(8):1510-9.
2001: Nai-Kong V Cheung; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; SV Gollamudi; Glenn Heller; William Gerald; S Yeh; Ronald Finn; Steven M Larson; David Wuest; M Byrnes; E Dantis; Jaume Mora; Irene Y Cheung; NS Rosenfield; Sara Abramson; Richard J O'Reilly
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
Medical and pediatric oncology 2001;36(1):227-30.
2001: Carol D Morris; Richard Gorlick; G Huvos; Glenn Heller; Paul A Meyers; John Healey
Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma.
Clinical orthopaedics and related research 2001;(382):59-65.
2001: W Kevin Kelly; Tracy Curley; Susan F Slovin; Glenn Heller; John McCaffrey; Dean F Bajorin; A Ciolino; Kevin Regan; Morton K Schwartz; Philip W Kantoff; D George; William K Oh; M Smith; D Kaufman; Eric J Small; Lawrence H Schwartz; Steven M Larson; William Tong; Howard I Scher
Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):44-53.
2000: Brian H Kushner; Glenn Heller; Kim Kramer; Nai-Kong V Cheung
Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
Cancer 2000;89(10):2122-30.
2000: Melissa Fazzari; Glenn Heller; Howard I Scher
The phase II/III transition. Toward the proof of efficacy in cancer clinical trials.
Controlled clinical trials 2000;21(4):360-8.
2000: Chad May; Stefano Rivella; JA Callegari; Glenn Heller; K M Gaensler; L Luzzatto; Michel Sadelain
Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.
Nature 2000;406(6791):82-6.
2000: Nai-Kong V Cheung; Hong-Fen Guo; Glenn Heller; Irene Y Cheung
Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2653-60.
2000: Luis H Camacho; Steven L Soignet; Suzanne M Chanel; R Ho; Glenn Heller; David A Scheinberg; R Ellison; RP Warrell
Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(13):2620-5.
2000: Howard I Scher; Glenn Heller
Clinical states in prostate cancer: toward a dynamic model of disease progression.
Urology 2000;55(3):323-7.
2000: J Mora; Nai-Kong V Cheung; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Melissa Fazzari; Glenn Heller; L Chen; W L Gerald
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.
The Journal of molecular diagnostics : JMD 2000;2(1):37-46.
1999: VK Prasad; Glenn Heller; Nancy A Kernan; Richard J O'Reilly; SY Yang
The probability of HLA-C matching between patient and unrelated donor at the molecular level: estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles.
Transplantation 1999;68(7):1044-50.
1999: David B Agus; Howard I Scher; Brian Higgins; William D Fox; Glenn Heller; Melissa Fazzari; Carlos Cordon-Cardo; David W Golde
Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models.
Cancer research 1999;59(19):4761-4.
1999: Richard Gorlick; Andrew G Huvos; Glenn Heller; A Aledo; G P Beardsley; John Healey; Paul A Meyers
Expression of HER2/erbB-2 correlates with survival in osteosarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2781-8.
1999: Ira Bergman; MA Barmada; Glenn Heller; Judith A Griffin; Nai-Kong V Cheung
Treatment of neoplastic meningeal xenografts by intraventricular administration of an antiganglioside monoclonal antibody, 3F8.
International journal of cancer. Journal international du cancer 1999;82(4):538-48.
1999: Nai-Kong V Cheung; Glenn Heller; Brian H Kushner; Kim Kramer
Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?
Medical and pediatric oncology 1999;32(2):84-7.
1999: Trudy N Small; Esperanza B Papadopoulos; Farid Boulad; P Black; Hugo Castro-Malaspina; Barrett H Childs; Nancy Collins; AP Gillio; Diane George; Ann Jakubowski; Glenn Heller; Melissa Fazzari; Nancy A Kernan; S MacKinnon; P Szabolcs; James W Young; Richard J O'Reilly
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions.
Blood 1999;93(2):467-80.
1999: Farid Boulad; Peter G Steinherz; B Reyes; Glenn Heller; AP Gillio; Trudy N Small; Joel A Brochstein; Nancy A Kernan; Richard J O'Reilly
Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):197-207.
1999: VK Prasad; Nancy A Kernan; Glenn Heller; Richard J O'Reilly; SY Yang
HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRB1 alleles: impact of serological vs. DNA typing for HLA-A and -B loci.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(2):77-85.
1999: VK Prasad; Nancy A Kernan; Glenn Heller; Richard J O'Reilly; SY Yang
DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1.
Blood 1999;93(1):399-409.
1998: Brian H Kushner; Nai-Kong V Cheung; Kim Kramer; Glenn Heller; Suresh C Jhanwar
Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3880-9.
1998: Brian H Kushner; Glenn Heller; Nai-Kong V Cheung; Norma Wollner; Kim Kramer; Dean F Bajorin; Tatyana Polyak; Paul A Meyers
High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3016-20.
1998: J S Wunder; G Paulian; Andrew G Huvos; Glenn Heller; Paul A Meyers; John Healey
The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.
The Journal of bone and joint surgery. American volume 1998;80(7):1020-33.
1998: Paul A Meyers; Richard Gorlick; Glenn Heller; Ephraim S Casper; J Lane; Andrew G Huvos; John Healey
Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2452-8.
1998: J Aisenberg; K Hsieh; G Kalaitzoglou; E Whittam; Glenn Heller; R Schneider; Charles A Sklar
Bone mineral density in young adult survivors of childhood cancer.
Journal of pediatric hematology/oncology 1998;20(3):241-5.
1998: A Aledo; Glenn Heller; L Ren; Sharon L Gardner; Ira J Dunkel; S W McKay; Carlos D Flombaum; Arthur E Brown
Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service.
Journal of pediatric hematology/oncology 1998;20(3):215-21.
1998: Farid Boulad; Nancy A Kernan; Michael P LaQuaglia; Glenn Heller; KL Lindsley; NS Rosenfield; Sara J Abramson; William L Gerald; Trudy N Small; AP Gillio; S C Gulati; Richard J O'Reilly; F Ghavimi
High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1697-706.
1998: Kurt D Newman; T Black; Glenn Heller; Richard G Azizkhan; GW Holcomb; Charles A Sklar; V Vlamis; Gerald M Haase; Michael P LaQuaglia
Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group.
Annals of surgery 1998;227(4):533-41.
1998: Esperanza B Papadopoulos; M H Carabasi; Hugo Castro-Malaspina; Barrett H Childs; S Mackinnon; Farid Boulad; AP Gillio; Nancy A Kernan; Trudy N Small; P Szabolcs; J Taylor; Joachim Yahalom; N H Collins; S A Bleau; P M Black; Glenn Heller; Richard J O'Reilly; James W Young
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.
Blood 1998;91(3):1083-90.
1998: Warren P Mason; AC Grovas; Steven Halpern; Ira J Dunkel; James Garvin; Glenn Heller; Marc K Rosenblum; Sharon L Gardner; David Lyden; SA Sands; D Puccetti; KL Lindsley; TE Merchant; B O'Malley; LA Bayer; M M Petriccione; J Allen; Jonathan Lester Finlay
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):210-21.
1997: I Bergman; Regina I Jakacki; Glenn Heller; Jonathan Lester Finlay
Treatment of standard risk medulloblastoma with craniospinal irradiation, carboplatin, and vincristine.
Medical and pediatric oncology 1997;29(6):563-7.
1997: Dennis H Kraus; NC Saenz; SV Gollamudi; Glenn Heller; M Moustakis; S Gardiner; William L Gerald; F Ghavimi; Michael P LaQuaglia
Pediatric rhabdomyosarcoma of the head and neck.
American journal of surgery 1997;174(5):556-60.
1997: Nai-Kong V Cheung; Glenn Heller; Brian H Kushner; C Liu; Irene Y Cheung
Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2807-17.
1997: G Michel; Farid Boulad; Trudy N Small; P Black; Glenn Heller; Hugo Castro-Malaspina; Barrett H Childs; AP Gillio; Esperanza B Papadopoulos; James W Young; Nancy A Kernan; Richard J O'Reilly
Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.
Bone marrow transplantation 1997;20(2):107-12.
1997: Trudy N Small; D Avigan; Bo Dupont; K Smith; P Black; Glenn Heller; Tatyana Polyak; Richard J O'Reilly
Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):65-75.
1997: Steven L Soignet; A Fleischauer; Tatyana Polyak; Glenn Heller; RP Warrell
All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study.
Cancer chemotherapy and pharmacology 1997;40 Suppl():S25-9.
1996: Casilda Balmaceda; Glenn Heller; Marc K Rosenblum; B Diez; Judith G Villablanca; S Kellie; P Maher; V Vlamis; R W Walker; Steven Leibel; Jonathan Lester Finlay
Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):2908-15.
1996: V Papadakis; Cuiwen Tan; Glenn Heller; Charles A Sklar
Growth and final height after treatment for childhood Hodgkin disease.
Journal of pediatric hematology/oncology 1996;18(3):272-6.
1996: Sharon E Oberfield; D Soranno; A Nirenberg; Glenn Heller; Jeffrey C Allen; Raphael David; L S Levine; Charles A Sklar
Age at onset of puberty following high-dose central nervous system radiation therapy.
Archives of pediatrics & adolescent medicine 1996;150(6):589-92.
1996: S Mackinnon; L Barnett; Glenn Heller
Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
Bone marrow transplantation 1996;17(4):643-7.
1996: Kenneth G Lucas; Trudy N Small; Glenn Heller; Bo Dupont; Richard J O'Reilly
The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.
Blood 1996;87(6):2594-603.
1996: L B Faulkner; KL Lindsley; U Kher; Glenn Heller; P Black; Jonathan Lester Finlay
High-dose chemotherapy with autologous marrow rescue for malignant brain tumors: analysis of the impact of prior chemotherapy and cranio-spinal irradiation on hematopoietic recovery.
Bone marrow transplantation 1996;17(3):389-94.
1996: Kenneth G Lucas; Arthur E Brown; Donald Armstrong; D Chapman; Glenn Heller
The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Cancer 1996;77(4):791-8.
1996: I Sahdev; Richard J O'Reilly; P Black; Glenn Heller; M Hoffmann
Interleukin-1 production following T-cell-depleted and unmodified marrow grafts.
Pediatric hematology and oncology 1996;13(1):55-67.
1995: V Papadakis; K F Ferguson; Glenn Heller; Nancy A Kernan
In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Experimental hematology 1995;23(14):1422-30.
1995: J M Wheatley; N S Rosenfield; Glenn Heller; D Feldstein; Michael P LaQuaglia
Validation of a technique of computer-aided tumor volume determination.
The Journal of surgical research 1995;59(6):621-6.
1995: A Scaradavou; Glenn Heller; Charles A Sklar; L Ren; F Ghavimi
Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma.
Cancer 1995;76(10):1860-7.
1995: L B Faulkner; S I Hajdu; U Kher; Michael P LaQuaglia; P R Exelby; Glenn Heller; Norma Wollner
Pediatric desmoid tumor: retrospective analysis of 63 cases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2813-8.
1995: Brian H Kushner; Paul A Meyers; W L Gerald; John Healey; Michael P LaQuaglia; Patrick J Boland; Norma Wollner; Ephraim S Casper; A Aledo; Glenn Heller
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2796-804.
1995: Z Huma; Farid Boulad; P Black; Glenn Heller; Charles A Sklar
Growth in children after bone marrow transplantation for acute leukemia.
Blood 1995;86(2):819-24.
1995: V Papadakis; T Diaz-Barrientos; Glenn Heller; N H Collins; S McKeever; Nancy A Kernan
Serum granulocyte colony-stimulating factor (G-CSF) levels after allogeneic T cell-depleted marrow transplantation.
Bone marrow transplantation 1995;15(6):955-61.
1995: Farid Boulad; M Bromley; P Black; Glenn Heller; K Sarafoglou; AP Gillio; Esperanza B Papadopoulos; Charles A Sklar
Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation.
Bone marrow transplantation 1995;15(1):71-6.
1994: Linda Vahdat; Peter Maslak; W H Miller; A Eardley; Glenn Heller; David A Scheinberg; RP Warrell
Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.
Blood 1994;84(11):3843-9.
1994: Brian H Kushner; Michael P LaQuaglia; M A Bonilla; KL Lindsley; N Rosenfield; S Yeh; J Eddy; W L Gerald; Glenn Heller; Nai-Kong V Cheung
Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2607-13.
1994: Michael P LaQuaglia; Brian H Kushner; Glenn Heller; M A Bonilla; KL Lindsley; Nai-Kong V Cheung
Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome.
Journal of pediatric surgery 1994;29(8):1162-5; discussion 1165-6.
1994: A M Eardley; Glenn Heller; RP Warrell
Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
Leukemia 1994;8(6):934-9.
1994: RP Warrell; Peter Maslak; A Eardley; Glenn Heller; W H Miller; S R Frankel
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience.
Leukemia 1994;8(6):929-33.
1994: S Mackinnon; L Barnett; Glenn Heller; Richard J O'Reilly
Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia.
Blood 1994;83(11):3409-16.
1994: Michael P LaQuaglia; C Caldwell; A Lucas; M Corbally; Glenn Heller; L Steinherz; Arthur E Brown; Jeffrey S Groeger; P R Exelby
A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children.
Journal of pediatric surgery 1994;29(6):742-5.
1994: Nai-Kong V Cheung; Irene Y Cheung; A Canete; S J Yeh; Brian H Kushner; M A Bonilla; Glenn Heller; Steven M Larson
Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.
Cancer research 1994;54(8):2228-33.
1994: S R Frankel; A Eardley; Glenn Heller; Ellin Berman; W H Miller; Ethan Dmitrovsky; RP Warrell
All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
Annals of internal medicine 1994;120(4):278-86.
1994: Michael P LaQuaglia; Glenn Heller; F Ghavimi; Ephraim S Casper; V Vlamis; S Hajdu; Murray F Brennan
The effect of age at diagnosis on outcome in rhabdomyosarcoma.
Cancer 1994;73(1):109-17.
1994: RP Warrell; Peter Maslak; A Eardley; Glenn Heller; W H Miller; S R Frankel
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience.
Leukemia 1994;8 Suppl 2():S33-7.
1993: Peter G Steinherz; Arlene Redner; L Steinherz; Paul A Meyers; Cuiwen Tan; Glenn Heller
Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol.
Cancer 1993;72(10):3120-30.
1993: AP Gillio; L B Faulkner; BLANCHE ALTER; L Reilly; R Klafter; Glenn Heller; D C Young; Jeffrey Lipton; Malcolm A S Moore; Richard J O'Reilly
Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3.
Blood 1993;82(3):744-51.
1993: AP Gillio; L B Faulkner; BLANCHE ALTER; L Reilly; R Klafter; Glenn Heller; D C Young; Jeffrey Lipton; Malcolm A S Moore; Richard J O'Reilly
Successful treatment of Diamond-Blackfan anemia with interleukin 3.
Stem cells (Dayton, Ohio) 1993;11 Suppl 2():123-30.
1993: Norma Wollner; P Exelby; KL Lindsley; P Lieberman; Daniel A Filippa; Glenn Heller
Primary peripheral nodal lymphoma in children.
Cancer 1993;71(11):3670-9.
1993: A Kritz; John Crown; Robert J Motzer; Lilian Reich; Glenn Heller; M P Moore; N Hamilton; Tzy-Jyun Yao; Robert T Heelan; J G Schneider
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.
Cancer 1993;71(8):2515-21.
1993: Peter Maslak; W H Miller; Glenn Heller; David A Scheinberg; Ethan Dmitrovsky; RP Warrell
CD2 expression and PML/RAR-alpha transcripts in acute promyelocytic leukemia.
Blood 1993;81(6):1666.
1993: Paul A Meyers; Glenn Heller; John Healey; Andrew G Huvos; A Applewhite; M Sun; Michael P LaQuaglia
Osteogenic sarcoma with clinically detectable metastasis at initial presentation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):449-53.
1993: Ira Bergman; E Arbit; Marc K Rosenblum; Steven M Larson; Glenn Heller; Nai-Kong V Cheung
Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8.
Journal of neuro-oncology 1993;15(3):235-42.
1993: Paul A Meyers; Glenn Heller; V Vlamis
Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering.
Cancer treatment and research 1993;62():309-22.
1992: S Mackinnon; L Barnett; J H Bourhis; P Black; Glenn Heller; Richard J O'Reilly
Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
Blood 1992;80(12):3235-41.
1992: David P Wood Jr; Harry W Herr; Glenn Heller; V Vlamis; Pramod C Sogani; Robert J Motzer; W R Fair; George J Bosl
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors.
The Journal of urology 1992;148(6):1812-5; discussion 1815-6.
1992: Michael P LaQuaglia; Glenn Heller; Daniel A Filippa; A Karasakalides; V Vlamis; Norma Wollner; Warren E Enker; A M Cohen; P R Exelby
Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma.
Journal of pediatric surgery 1992;27(8):1085-9; discussion 1089-90.
1992: James W Young; Esperanza B Papadopoulos; I Cunningham; Hugo Castro-Malaspina; N Flomenberg; M H Carabasi; S C Gulati; Joel A Brochstein; Glenn Heller; P Black
T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission.
Blood 1992;79(12):3380-7.
1992: Glenn Heller; J S Simonoff
Prediction in censored survival data: a comparison of the proportional hazards and linear regression models.
Biometrics 1992;48(1):101-15.
1992: Paul A Meyers; Glenn Heller; John Healey
Retrospective review of neoadjuvant chemotherapy for osteogenic sarcoma.
Journal of the National Cancer Institute 1992;84(3):202-4.
1992: Paul A Meyers; Glenn Heller; John Healey; Andrew G Huvos; J Lane; R Marcove; A Applewhite; V Vlamis; G Rosen
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):5-15.
1991: L J Steinherz; Peter G Steinherz; C T Tan; Glenn Heller; M L Murphy
Cardiac toxicity 4 to 20 years after completing anthracycline therapy.
JAMA : the journal of the American Medical Association 1991;266(12):1672-7.
1991: Glenn Heller; Nai-Kong V Cheung
Dose-intensity analysis and randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1715-6.
1991: RP Warrell; W K Murphy; P Schulman; P J O'Dwyer; Glenn Heller
A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1467-75.
1991: Nai-Kong V Cheung; Glenn Heller
Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(6):1050-8.
1991: Ellin Berman; Glenn Heller; J Santorsa; S McKenzie; T Gee; Sanford J. Kempin; S Gulati; M Andreeff; Jonathan E Kolitz; JL Gabrilove
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia.
Blood 1991;77(8):1666-74.
1991: Nai-Kong V Cheung; Glenn Heller; Brian H Kushner; L Burch; Richard J O'Reilly
Stage IV neuroblastoma more than 1 year of age at diagnosis: major response to chemotherapy and survival durations correlated strongly with dose intensity.
Progress in clinical and biological research 1991;366():567-73.
1990: Trudy N Small; C A Keever; S Weiner-Fedus; Glenn Heller; Richard J O'Reilly; N Flomenberg
B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny.
Blood 1990;76(8):1647-56.
1990: G S Incefy; N Flomenberg; Glenn Heller; Nancy A Kernan; Joel A Brochstein; D Kirkpatrick; N Kapoor; S Groshen; Richard J O'Reilly
Evidence that appearance of thymulin in plasma follows lymphoid chimerism and precedes development of immunity in patients with lethal combined immunodeficiency transplanted with T cell-depleted haploidentical marrow.
Transplantation 1990;50(1):55-61.
1990: Ellin Berman; Glenn Heller; Sanford J. Kempin; T Gee; L L Tran; Bayard Clarkson
Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a.
Blood 1990;75(4):839-45.
1990: Brian H Kushner; S C Gulati; Richard J O'Reilly; Glenn Heller; Nai-Kong V Cheung
Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro.
Medical and pediatric oncology 1990;18(6):454-8.
1989: F Ghavimi; L R Mandell; Glenn Heller; S I Hajdu; P Exelby
Prognosis in childhood rhabdomyosarcoma of the extremity.
Cancer 1989;64(11):2233-7.
1989: Nancy A Kernan; Claudio Bordignon; Glenn Heller; I Cunningham; Hugo Castro-Malaspina; B Shank; N Flomenberg; J Burns; SY Yang; P Black
Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants.
Blood 1989;74(6):2227-36.
1989: Michael P LaQuaglia; F Ghavimi; Glenn Heller; Harry W Herr; L R Mandell; M Corbally; S Hajdu; P Exelby
Mortality in pediatric paratesticular rhabdomyosarcoma: a multivariate analysis.
The Journal of urology 1989;142(2 Pt 2):473-8; discussion 489.
1989: C A Keever; Trudy N Small; N Flomenberg; Glenn Heller; K Pekle; P Black; A Pecora; AP Gillio; Nancy A Kernan; Richard J O'Reilly
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.
Blood 1989;73(5):1340-50.
1989: Ellin Berman; V Raymond; T Gee; Sanford J. Kempin; S Gulati; M Andreeff; Jonathan E Kolitz; JL Gabrilove; Glenn Heller; C W Young
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
Seminars in oncology 1989;16(1 Suppl 2):30-4.
1988: Michael P LaQuaglia; M T Corbally; Glenn Heller; P R Exelby; Murray F Brennan
Recurrence and morbidity in differentiated thyroid carcinoma in children.
Surgery 1988;104(6):1149-56.